Analysts Are Bullish on Top Healthcare Stocks: Opko Health (OPK), Achieve Life Sciences (ACHV)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Opko Health (OPK – Research Report), Achieve Life Sciences (ACHV – Research Report) and Atossa Therapeutics (ATOS – Research Report) with bullish sentiments.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Opko Health (OPK)
In a report released today, Yi Chen from H.C. Wainwright maintained a Buy rating on Opko Health, with a price target of $3.00. The company’s shares closed last Wednesday at $1.30.
According to TipRanks.com, Chen is a 3-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Opko Health with a $2.46 average price target.
See the top stocks recommended by analysts >>
Achieve Life Sciences (ACHV)
In a report released today, Brandon Folkes from H.C. Wainwright maintained a Buy rating on Achieve Life Sciences, with a price target of $12.00. The company’s shares closed last Wednesday at $5.36, close to its 52-week high of $5.59.
According to TipRanks.com, Folkes is a 3-star analyst with an average return of
Achieve Life Sciences has an analyst consensus of Strong Buy, with a price target consensus of $14.40.
Atossa Therapeutics (ATOS)
In a report released today, Emily Bodnar from H.C. Wainwright maintained a Buy rating on Atossa Therapeutics, with a price target of $7.00. The company’s shares closed last Wednesday at $0.61.
According to TipRanks.com, Bodnar is a 4-star analyst with an average return of
Currently, the analyst consensus on Atossa Therapeutics is a Strong Buy with an average price target of $6.33.
